Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qunli Xiong

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Journal of Hematology & Oncology|June 22, 2023
Small RNA modifications: regulatory molecules and potential applicationsQunli Xiong, Yaguang Zhang
Science China. Life Sciences|December 8, 2024
Regulation and application of m<sup>6</sup>A modification in tumor immunityQunli Xiong, Yaguang Zhang, Ying Zheng, et al.
Journal of Clinical Medicine|December 23, 2022
Pancreatic Adenosquamous Carcinoma: A Rare Pathological Subtype of Pancreatic CancerQunli Xiong, Zhiwei Zhang, Yongfeng Xu, et al.
Genes|November 11, 2022
Small Non-Coding RNAs in Human CancerQunli Xiong, Yaguang Zhang, Junjun Li, et al.
International Journal of Molecular Sciences|October 26, 2024
Establishment and Verification of a Novel Gene Signature Connecting Hypoxia and Lactylation for Predicting Prognosis and Immunotherapy of Pancreatic Ductal Adenocarcinoma Patients by Integrating Multi-Machine Learning and Single-Cell AnalysisYing Zheng, Yang Yang, Qunli Xiong, et al.
Journal of Cancer Research and Clinical Oncology|June 24, 2024
Identified γ-glutamyl cyclotransferase (GGCT) as a novel regulator in the progression and immunotherapy of pancreatic ductal adenocarcinoma through multi-omics analysis and experimentsYing Zheng, Qunli Xiong, Yang Yang, et al.
Translational Oncology|July 27, 2024
FUBP1 in human cancer: Characteristics, functions, and potential applicationsFan Zhang, Qunli Xiong, Min Wang, et al.
Frontiers in Oncology|May 14, 2023
The dual role of p63 in cancerYongfeng Xu, Xiaojuan Yang, Qunli Xiong, et al.
Peerj|September 16, 2024
Serum PCSK9 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancerYing Xu, Yongfeng Xu, Yang Yang, et al.
Journal of Clinical Medicine|February 25, 2023
The PD-L1 Expression and Tumor-Infiltrating Immune Cells Predict an Unfavorable Prognosis in Pancreatic Ductal Adenocarcinoma and Adenosquamous CarcinomaZhiwei Zhang, Qunli Xiong, Yongfeng Xu, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Journal of Hematology & Oncology|June 22, 2023
Small RNA modifications: regulatory molecules and potential applicationsQunli Xiong, Yaguang Zhang
Science China. Life Sciences|December 8, 2024
Regulation and application of m<sup>6</sup>A modification in tumor immunityQunli Xiong, Yaguang Zhang, Ying Zheng, et al.
Journal of Clinical Medicine|December 23, 2022
Pancreatic Adenosquamous Carcinoma: A Rare Pathological Subtype of Pancreatic CancerQunli Xiong, Zhiwei Zhang, Yongfeng Xu, et al.
Genes|November 11, 2022
Small Non-Coding RNAs in Human CancerQunli Xiong, Yaguang Zhang, Junjun Li, et al.
International Journal of Molecular Sciences|October 26, 2024
Establishment and Verification of a Novel Gene Signature Connecting Hypoxia and Lactylation for Predicting Prognosis and Immunotherapy of Pancreatic Ductal Adenocarcinoma Patients by Integrating Multi-Machine Learning and Single-Cell AnalysisYing Zheng, Yang Yang, Qunli Xiong, et al.
Journal of Cancer Research and Clinical Oncology|June 24, 2024
Identified γ-glutamyl cyclotransferase (GGCT) as a novel regulator in the progression and immunotherapy of pancreatic ductal adenocarcinoma through multi-omics analysis and experimentsYing Zheng, Qunli Xiong, Yang Yang, et al.
Translational Oncology|July 27, 2024
FUBP1 in human cancer: Characteristics, functions, and potential applicationsFan Zhang, Qunli Xiong, Min Wang, et al.
Frontiers in Oncology|May 14, 2023
The dual role of p63 in cancerYongfeng Xu, Xiaojuan Yang, Qunli Xiong, et al.
Peerj|September 16, 2024
Serum PCSK9 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancerYing Xu, Yongfeng Xu, Yang Yang, et al.
Journal of Clinical Medicine|February 25, 2023
The PD-L1 Expression and Tumor-Infiltrating Immune Cells Predict an Unfavorable Prognosis in Pancreatic Ductal Adenocarcinoma and Adenosquamous CarcinomaZhiwei Zhang, Qunli Xiong, Yongfeng Xu, et al.
Pageof 3